Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reduce the Risk of Breast Cancer Recurrence”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Testing effectiveness (Phase 2)Looking for participantsNCT07104266
What this trial is testing

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Who this might be right for
Triple-Negative Breast Cancer
Université de Sherbrooke 30
Large-scale testing (Phase 3)Study completedNCT00639210
What this trial is testing

BREAST CANCER AND EXERCISE

Who this might be right for
Prevent Osteoporosis and Osteoporotic FracturesImprove Quality of LifeImprove Weight Control, and Muscular and Cardiovascular Fitness+3 more
Finnish Breast Cancer Group 573